Skip to main content
. Author manuscript; available in PMC: 2024 Apr 5.
Published in final edited form as: Immunohorizons. 2021 Aug 25;5(8):675–686. doi: 10.4049/immunohorizons.2100056

TABLE I.

Description of experimental groups analyzed

Dataset Strain Individual or Pooled Tissue Age at Experiment Start (wk) Treatments Original Publication
Normal mouse C57BL/6J Pooled Spleen 9–11 None (19)
CASIS C57BL/6Tac Individual Spleen 35 Spaceflight (5)
TARDIS C57BL/6J Individual Spleen and bone marrow 10 AOS and/or TT and/or CpG1826 Spleen (6)
Bone marrow (7)
Hypervaccination C57BL/6J Pooled Spleen and bone marrow 10 Vaccinated three times with TT and CpG1826 Data not shown